Study of an oral weight loss medication in Chinese adults with overweight or obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests an investigational oral medication to help Chinese adults with overweight or obesity, plus related health issues, lose weight. It focuses on improving weight loss and overall health in this group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- Your body mass index (BMI) is between 24 and 30, or between 28 and 30 if you have no weight-related health problems.
- You have at least one weight-related health problem (like high blood pressure, high cholesterol, sleep apnea, fatty liver, or heart disease).
- You have tried to lose weight before but haven't been able to keep it off.
- You do not have type 1 or type 2 diabetes, or any other type of diabetes, or a history of diabetic coma.
- Your weight has been stable (no big changes) for the past 3 months.
- You have never had pancreatitis.
- You do not have a personal or family history of medullary thyroid carcinoma or MEN2 syndrome.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This trial tests a medication for children and teens with obesity or overweight who have not been able to lose enough weight with diet and exercise alone. It aims to see if a new treatment can help them safely lose weight and improve related health problems.
This study tests a once-daily pill (orforglipron) to help adolescents with obesity or overweight plus related health problems lose weight. It offers a new option for teens who have struggled to lose weight with diet and exercise alone.
This study tests an investigational medication called elecoglipron for weight loss in Asian adults who are overweight or have obesity, with or without type 2 diabetes. It may help participants lose weight and improve health.
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
This study tests an experimental medicine (eloralintide) to see if it can help people with overweight or obesity lose weight without having diabetes. The medicine works by affecting hormones that help control appetite and body weight.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.